Eyeworld

INDICATIONS AND USAGE OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain. Reimbursement information is based on Omeros data on fi le. Omeros does not guarantee reimbursement for any particular patient. Contact 1-844-OMEROS1 (1-844-663-7671) for more information about how to submit for OMIDRIA reimbursement. PROVEN 46 TIMES BETTER THAN INTRACAMERAL PHENYLEPHRINE OR KETOROLAC ALONE 2 FULLY REIMBURSABLE ACROSS ALL PAYER TYPES 3,4 NO EFFECT ON PHYSICIAN FEES 3 PASSTHROUGH PAYMENTS HAVE NO EFFECT ON THE HEALTHCARE SYSTEM 3 ® References: 1. OMIDRIA [package insert]. Seattle, WA: Omeros Corporation; 2015. 2. Omeros data on fi le. 3. Federal Register, April 7, 2000, 65 FR. 4. Kaiser Family Foundation analysis of the CMS Medicare Current Benefi ciary Survey Cost and Use File, 2010. 5. Lindstrom RL, et al. Clin Ophthalmol. 2014;8:1735-1744. 6. Katsev D, Katsev C, Pinnow J. Intracameral ketorolac concentration after topical ketorolac administration prior to cataract surgery. Electronic poster session presented at: American Society of Cataract and Refractive Surgery. 2015 ASCRS-ASOA Symposium and Congress; 2015 Apr 17-21; San Diego, CA. Study sponsored by Omeros Corporation. 7. Florio V, Cowan L, Prusakiewicz JJ, Bentley E, Waterbury LD. Ocular tissue distribution of ketorolac after administration of OMS302 to dogs during IOL replacement. Electronic poster session presented at: American Society of Cataract and Refractive Surgery. 2015 ASCRS-ASOA Symposium and Congress; 2015 April 17-21; San Diego, CA. 8. Waterbury LD, et al. Curr Med Res Opin. 2006;22:1133-1140. 9. Hovanesian JA, et al. J Cataract Refract Surg. 2015 [in press].

• Cover